Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) breast cancer patients in the United States: 2002-2012. [electronic resource]
Producer: 20150601Description: 1537-45 p. digitalISSN:- 1473-4877
- Aged
- Aged, 80 and over
- Antineoplastic Agents, Hormonal -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Databases, Factual
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Guideline Adherence -- statistics & numerical data
- Humans
- Middle Aged
- Neoplasm Metastasis
- Postmenopause
- Practice Guidelines as Topic
- Practice Patterns, Physicians' -- statistics & numerical data
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
- Retrospective Studies
- United States
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.